Earnings results often give us a good indication of what direction the company will take in the months ahead. With Q4 now behind us, let’s have a look at Health Catalyst (NASDAQ:HCAT) and its peers.
Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the silo-ed data.
The 4 data analytics stocks we track reported a mixed Q4; on average, revenues beat analyst consensus estimates by 3.9%, while on average next quarter revenue guidance was 0.13% above consensus. Tech stocks have had a rocky start in 2022, but data analytics stocks held their ground better than others, with share price down 8.45% since earnings, on average.
Health Catalyst (NASDAQ:HCAT)
Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.
Health Catalyst reported revenues of $64.7 million, up 21.4% year on year, beating analyst expectations by 2.48%. It was a weaker quarter for the company, with revenue guidance missing analysts' expectations for both the full year and the next quarter.
“In the fourth quarter of 2021, I am pleased to share that we achieved strong performance across our business, including exceeding the mid-point of our quarterly guidance for both revenue and Adjusted EBITDA,” said Dan Burton, CEO of Health Catalyst.
Health Catalyst delivered the weakest performance against analyst estimates and slowest revenue growth of the whole group. The stock is up 4.46% since the results and currently trades at $27.63.
Best Q4: Domo (NASDAQ:DOMO)
Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ:DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.
Domo reported revenues of $69.9 million, up 23.1% year on year, beating analyst expectations by 4.31%. It was a very strong quarter for the company, with a very optimistic guidance for the next quarter and a full year guidance beating analysts' expectations.
Domo scored the highest full year guidance raise among its peers. The stock is up 17.3% since the results and currently trades at $51.46.
Is now the time to buy Domo? Access our full analysis of the earnings results here, it's free.
Weakest Q4: Amplitude (NASDAQ:AMPL)
Born out of a failed voice recognition startup by founder Spenser Skates, Amplitude (NASDAQ:AMPL) is data analytics software helping companies improve and optimize their digital products.
Amplitude reported revenues of $49.4 million, up 75.1% year on year, beating analyst expectations by 5.26%. It was a weaker quarter for the company, with revenue guidance missing analysts' expectations for both the full year and the next quarter.
Amplitude pulled off the strongest analyst estimates beat and fastest revenue growth, but had the weakest full year guidance update in the group. The company added 180 customers to a total of 1,597. The stock is down 54.4% since the results and currently trades at $18.94.
Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.
Palantir reported revenues of $432.8 million, up 34.3% year on year, beating analyst expectations by 3.54%. It was a strong quarter for the company, with a solid top line growth and revenue guidance for the next quarter above analysts' expectations.
The stock is down 1.07% since the results and currently trades at $13.82.
The author has no position in any of the stocks mentioned